Please use this identifier to cite or link to this item: doi:10.22028/D291-42215
Title: Can glucose facilitate fear exposure? Randomized, placebo-controlled trials on the effects of glucose administration on fear extinction processes
Author(s): Hauck, Alexander
Michael, Tanja
Issler, Tobias C.
Klein, Steven
Lass-Hennemann, Johanna
Ferreira de Sá, Diana S.
Language: English
Title: Behaviour Research and Therapy
Volume: 178
Publisher/Platform: Elsevier
Year of Publication: 2024
Free key words: Fear conditioning
Fear extinction
Extinction recall
Reinstatement
Glucose
Psychotherapy adjuvants
DDC notations: 150 Psychology
Publikation type: Journal Article
Abstract: Previous studies showed that glucose has beneficial effects on memory function and can enhance contextual fear learning. To derive potential therapeutic interventions, further research is needed regarding the effects of glucose on fear extinction. In two experimental studies with healthy participants (Study 1: N = 68, 39 females; Study 2: N = 89, 67 females), we investigated the effects of glucose on fear extinction learning and its consolidation. Participants completed a differential fear conditioning paradigm consisting of acquisition, extinction, and return of fear tests: reinstatement, and extinction recall. US-expectancy ratings, skin conductance response (SCR), and fear potentiated startle (FPS) were collected. Participants were pseudorandomized and double-blinded to one of two groups: They received either a drink containing glucose or saccharine 20 min before (Study 1) or immediately after extinction (Study 2). The glucose group showed a significantly stronger decrease in differential FPS during extinction (Study 1) and extinction recall (Study 2). Additionally, the glucose group showed a significantly lower contextual anxiety at test of reinstatement (Study 2). Our findings provide first evidence that glucose supports the process of fear extinction, and in particular the consolidation of fear extinction memory, and thus has potential as a beneficial adjuvant to extinction-based treatments. Registered through the German Clinical Trials Registry (https://www.bfarm.de/EN/BfArM/Tasks/GermanClinical-Trials-Register/_node.html; Study 1: DRKS00010550; Study 2: DRKS00018933).
DOI of the first publication: 10.1016/j.brat.2024.104553
URL of the first publication: https://doi.org/10.1016/j.brat.2024.104553
Link to this record: urn:nbn:de:bsz:291--ds-422156
hdl:20.500.11880/37891
http://dx.doi.org/10.22028/D291-42215
ISSN: 0005-7967
Date of registration: 19-Jun-2024
Description of the related object: Supplementary data
Related object: https://ars.els-cdn.com/content/image/1-s2.0-S0005796724000809-mmc1.pdf
https://ars.els-cdn.com/content/image/1-s2.0-S0005796724000809-mmc2.pdf
Faculty: HW - Fakultät für Empirische Humanwissenschaften und Wirtschaftswissenschaft
Department: HW - Psychologie
Professorship: HW - Prof. Dr. Tanja Michael
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
1-s2.0-S0005796724000809-main.pdf8,25 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons